Page last updated: 2024-11-03

propranolol and Adenocarcinoma Of Kidney

propranolol has been researched along with Adenocarcinoma Of Kidney in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Albiñana, V1
Recio-Poveda, L1
González-Peramato, P1
Martinez-Piñeiro, L1
Botella, LM1
Cuesta, AM1
Piñar, D1
Boix, E1
Meana, JA1
Herrero, J1

Other Studies

2 other studies available for propranolol and Adenocarcinoma Of Kidney

ArticleYear
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.
    International journal of molecular sciences, 2022, Jan-25, Volume: 23, Issue:3

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hemangiobl

2022
Sunitinib-induced thyrotoxicosis.
    Journal of endocrinological investigation, 2009, Volume: 32, Issue:11

    Topics: Aged; Antineoplastic Agents; Carbimazole; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms;

2009